Patent · US Active

Methods of using an alpha-4-beta-7 heterodimer specific antagonist antibody

US9499620B2 · kind B2 · utility

4Cited by
3References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 26, 2014
Grant dateNov 22, 2016
Priority date—
Expiry dateSep 26, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There are disclosed alpha4beta7 heterodimer-specific antigen binding proteins, nucleic acids encoding them, and methods of making and using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.